Bladder Cancer

How We Developed a New Protocol for Treatment of Urethral Carcinoma

How We Developed a New Protocol for Treatment of Urethral Carcinoma

Faced with a harsh treatment option, a patient with genitourinary cancer helps create a treatment plan that preserves his self-image.

Smoking-related Cancer Deaths Highest in Southern United States

Smoking-related Cancer Deaths Highest in Southern United States

By

Smoking-attributable cancer mortality estimates have not been established by state; therefore, in this study, the proportion of cancer deaths among persons 35 years and older related to cigarette smoking in 2014 was calculated for each state and DC.

New Research Identifies Potential Bladder Cancer Chemotherapy Side Effect

By

A recent study undertaken sought to examine the effects of chemotherapy on bladder cancer cells and possible connections to later treatment resistance.

Nivolumab Monotherapy Active in Recurrent Metastatic Urothelial Carcinoma

By

Single-agent nivolumab induced durable clinical responses with a manageable safety profile in previously treated patients with locally advanced or metastatic urothelial carcinoma.

Mycobacteria Treatment for Bladder Cancer More Effective With Emulsification in Olive Oil

By

Emulsifying Mycobacterium brumae in olive oil appeared promising for producing a robust immune response in preclinical tests. Recent research has indicated that M brumae is a safer alternative to BCG.

Atezolizumab Approved for Locally Advanced or Metastatic Urothelial Carcinoma

Atezolizumab Approved for Locally Advanced or Metastatic Urothelial Carcinoma

By

US FDA granted accelerated approval to atezolizumab (TECENTRIQ), indicated for the treatment of locally advanced or metastatic UC in patients whose disease progressed during or following platinum-based chemotherapy, or in the neoadjuvant or adjuvant setting.

Well Water a Suspected Cause of Bladder Cancer in New England

Well Water a Suspected Cause of Bladder Cancer in New England

Researchers believe arsenic exposure might contribute to higher-than-normal rates of bladder cancer in the region.

Risk of Bladder Cancer Higher for Patients Taking a Specific Diabetes Medication

By

Pioglitazone use correlated with increased rates of bladder cancer across a large population. The risk of developing bladder cancer also increased with higher dose and longer use of the drug.

Adaptive IGRT for Urinary Bladder Cancer Is Clinically Feasible With Good Outcomes

By

A bladder preservation rate of 83% occurred at 3 years after a trimodality treatment approach for localized bladder cancer that used adaptive image-guided, intensity-modulated radiation therapy (IG-IMRT).

ASCO Endorses European Association of Urology Guideline on Bladder Cancer

ASCO Endorses European Association of Urology Guideline on Bladder Cancer

Guideline on muscle-invasive and metastatic bladder cancer, with qualifying statements

Diagnostic Tool Can Smell Bladder Cancer or Prostate Cancer in a Urine Sample

Diagnostic Tool Can Smell Bladder Cancer or Prostate Cancer in a Urine Sample

By

Recent developments in a gas chromatography tool might allow doctors to determine whether urologic cancers are present via a urine sample.

Adjuvant Chemo Associated With Improved Survival in Locally Advanced Bladder Cancer

Adjuvant Chemo Associated With Improved Survival in Locally Advanced Bladder Cancer

By

Adjuvant chemotherapy was associated with improved survival in patients with locally advanced bladder cancer.

Mental Health Status May Impact Bladder Cancer Surgery Outcomes

By

Mental health status prior to bladder cancer surgery may be associated with postoperative outcomes.

Investigational Immunotherapeutic Approach Increased Survival in Patients With Bladder Cancer

By

A novel immunotherapeutic approach improved outcomes for patients with advanced bladder cancer, according to a recent study.

Researchers develop a more efficient process for identifying personalized bladder cancer treatment

By

Researchers developed a way to personalize treatments for aggressive bladder cancer. Taking bladder tumors from individual patients, identifying actionable mutations, and grafting the tumors into mice, researchers were able to simultaneously test multiple therapies in the tumor models.

Increase in risk of bladder cancer is not statistically significant with use of pioglitazone

By

Although some previous studies have suggested an increased risk of bladder cancer with use of the diabetes drug pioglitazone, additional analysis has not found a statistically significant increased risk.

Older white males with advanced bladder cancer more likely to commit suicide

Older white males with advanced bladder cancer more likely to commit suicide

Older white males with advanced bladder cancer are the most likely to commit suicide among patients with genitourinary cancers.

Urine test could help to guide treatment of bladder cancer

A newly developed urine test could help to guide clinicians in the treatment of bladder cancer patients.

Laparoscopic surgery for bladder cancer leads to good long-term cancer control

By

The long-term survival rates following laparoscopic surgery for bladder cancer are not unlike survival rates for open surgery, according to research.

Immune blockade treatment promising for advanced bladder cancer

By

The antibody MPDL3280A, which blocks the protein PD-L1, resulted in tumor shrinkage in slightly over half of tested patients with advanced bladder cancer.

For bladder cancer, laparoscopic radical cystectomy effective at preventing recurrence

For bladder cancer, laparoscopic radical cystectomy effective at preventing recurrence

Long-term survival rates following laparoscopic surgery for bladder cancer are comparable to those of open surgery, according to recent study data.

No association found between thiazolidinediones and bladder cancer

No association found between thiazolidinediones and bladder cancer

There is no link between either pioglitazone or rosiglitazone and bladder cancer.

For patients with stage 2 or greater bladder cancer, care transitions linked with treatment delay

For patients with stage 2 or greater bladder cancer, care transitions linked with treatment delay

Patients with stage 2 or higher urothelial carcinoma who underwent a care transition more likely to experience a delay in treatment.

Quality of biopsy directly linked to survival in patients with bladder cancer

By

Researchers have demonstrated for the first time that the quality level of diagnostic staging using biopsy in patients with bladder cancer is directly linked with their survival.

Urologists key to informing patients of tobacco-bladder cancer link

Urologists key to informing patients of tobacco-bladder cancer link

Active smokers more knowledgeable than former smokers or nonsmokers, and often cite urologist as source of information.

Poor staging linked to mortality in bladder cancer

Poor staging linked to mortality in bladder cancer

In cases of bladder cancer, omission of muscle in specimen or its mention in pathology report is linked to increased mortality.

For patients with bladder cancer, invisible blood in urine may aid diagnosis

For patients with bladder cancer, invisible blood in urine may aid diagnosis

According to new research, invisible blood in the urine may be able to be used to diagnose bladder cancer.

Protein is predictive of treatment that makes radiotherapy for bladder cancer more effective

By

Scientists have identified a protein that could help doctors decide which patients with bladder cancer would benefit from a treatment that makes radiotherapy more effective, according to a new study.

Even after cancer diagnosis, 1 in 10 survivors continues to smoke

Even after cancer diagnosis, 1 in 10 survivors continues to smoke

A new study published in the journal Cancer Epidemiology, Biomarkers, & Prevention found that nearly 1 in 10 cancer survivors continued smoking despite their cancer diagnosis

A new target for aggressive bladder cancer found

A new target for aggressive bladder cancer found

An international team of scientists have discovered a faulty process in certain bladder cancers that could point to new ways to treat patients with an aggressive form of the disease.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs